Plasma lipoprotein(a) [Lp(a)] levels are largely genetically determined by sequences linked to the gene encoding apolipoprotein(a) [apo(a)], the distinct protein component of Lp(a). Apo(a) is highly polymorphic in length due to variation in the numbers of a sequence encoding the apo(a) kringle 4 domain, and plasma levels of Lp(a) are inversely correlated with apo(a) size. In 2 racially homogeneous Bantu populations from Tanzania differing in their dietary habits, we found that median plasma levels of Lp(a) were 48% lower in those living on a fish diet than in those living on a vegetarian diet. Considering the relationship between apo(a) size and Lp(a) plasma concentration, we have extensively evaluated apo(a) isoform distribution in the 2 populations to determine the impact of apo(a) size in the determination of Lp(a) values. The majority of individuals (82% of the fishermen and 80% of the vegetarians) had 2 expressed apo(a) alleles. Additionally, the fishermen had a high frequency of large apo(a) isoforms, whereas a higher frequency of small isoforms was found in the vegetarians. When subjects from the 2 groups were matched for apo(a) phenotype, the median Lp(a) value was 40% lower in Bantus on the fish diet than in those on the vegetarian diet. A significant inverse relationship was also found between plasma n-3 polyunsaturated fatty acids and Lp(a) levels (r=-0.24, P=0.01). The results of this study are consistent with the concept that a diet rich in n-3 polyunsaturated fatty acids, and not genetic differences, is responsible for the lower plasma levels of Lp(a) in the fish-eating Bantus and strongly suggest that a sustained fish-based diet is able to lower plasma levels of Lp(a).

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.atv.19.5.1250DOI Listing

Publication Analysis

Top Keywords

apoa size
16
plasma levels
16
levels lpa
16
lower plasma
12
apoa
10
lpa
9
plasma
8
plasma lipoproteina
8
fish diet
8
vegetarian diet
8

Similar Publications

Introduction: Dyslipidemia is characterized by changes in lipid and lipoprotein levels in the blood where phospholipid transfer protein (PLTP) helps to regulate and modulate the size of high-density lipoproteins (HDL), working on the reverse transport of cholesterol. ApoA-1 is the primary protein component of HDL, and certain genetic variants like rs5072, have been associated with hypertriglyceridemia in children. This study aimed to explore the association between PLTP concentrations and the effect of the genetic variant APOA1 rs5072 on hypertriglyceridemia and atherogenic dyslipidemia (AD) in the pediatric population of Southeastern Mexico.

View Article and Find Full Text PDF

Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin.

J Lipid Res

December 2024

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Electronic address:

Article Synopsis
  • * Current tests for measuring Lp(a) often assess total apo(a), which may not accurately reflect Lp(a) levels or the effects of new treatments.
  • * A new immunoassay developed for measuring Lp(a) particles showed better accuracy, indicating that muvalaplin's Lp(a)-lowering effects were previously underestimated by commercial tests, while lepodisiran's effects were consistent across both methods.
View Article and Find Full Text PDF

There are some limitations to using the body condition score (BCS) for client education to prevent obesity, hyperlipidemia-related diseases, and orthopedic diseases in dogs because it is hard to quantify in detail. Especially in small dogs, patellar luxation is a common orthopedic disease that is related to obesity and the hind leg muscle. In this pilot study, the author evaluated the thorax/thigh circumference ratio as a prognostic evaluation index, along with the BCS, for assessing patellar dislocation and other hyperlipidemia-related diseases and states such as hypertriglyceridemia and obesity-related orthopedic disease in small dogs.

View Article and Find Full Text PDF

Apolipoprotein A-I Mimetic Peptide Restores VEGF-induced Angiogenesis in Hypercholesterolemic Ischemic Heart by Reducing HDL Proinflammatory Properties.

J Cardiovasc Transl Res

October 2024

Division of Cardiac Surgery, Cardiovascular Diseases Institute, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhong Shan Er Road, Guangzhou, 510080, China.

Article Synopsis
  • VEGF-induced angiogenesis is hindered in hypercholesterolemia, but a peptide called D-4F may help improve this condition by reducing HDL's pro-inflammatory effects.
  • In a study, different mouse models were used to assess the impact of D-4F and VEGFA on heart function and angiogenesis after inducing a heart attack.
  • The results indicated that D-4F, when combined with VEGFA, enhanced angiogenesis and improved heart function in hypercholesterolemic mice by activating specific signaling pathways, although it did not have the same effect in another set of genetically modified mice.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed data from 503 midlife women, focusing on various HDL components and their changes over time to see their impact on cognitive functions like working memory and processing speed.
  • * Findings suggest that higher levels of certain HDL metrics are linked to better memory and cognitive performance, indicating that improving these HDL measures could be beneficial for cognitive health, especially in relation to Alzheimer’s disease.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!